These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11256573)

  • 1. Pathways of antigen processing and presentation.
    Watts C; Powis S
    Rev Immunogenet; 1999; 1(1):60-74. PubMed ID: 11256573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide binding and antigen presentation by class II histocompatibility glycoproteins.
    Jensen PE
    Biopolymers; 1997; 43(4):303-22. PubMed ID: 9316394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HLA system, antigen processing and presentation.
    Krensky AM
    Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural principles of MHC class II antigen presentation.
    Nelson CA; Fremont DH
    Rev Immunogenet; 1999; 1(1):47-59. PubMed ID: 11256572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
    Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
    J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ; Bakke O; Gregers TF
    Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.
    Wolf BJ; Princiotta MF
    Mol Immunol; 2011 Jan; 48(4):463-71. PubMed ID: 21067810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
    Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
    Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Processing of MHC class I presented antigens].
    van Endert P
    Med Sci (Paris); 2006; 22(8-9):727-32. PubMed ID: 16962047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I molecules, structure and function.
    Natarajan K; Li H; Mariuzza RA; Margulies DH
    Rev Immunogenet; 1999; 1(1):32-46. PubMed ID: 11256571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
    Stevanović S; Schild H
    Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.